Jessica A. Kahn

9.8k total citations
180 papers, 5.9k citations indexed

About

Jessica A. Kahn is a scholar working on Epidemiology, Health and Surgery. According to data from OpenAlex, Jessica A. Kahn has authored 180 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 125 papers in Epidemiology, 54 papers in Health and 49 papers in Surgery. Recurrent topics in Jessica A. Kahn's work include Cervical Cancer and HPV Research (116 papers), Vaccine Coverage and Hesitancy (48 papers) and Hepatitis B Virus Studies (47 papers). Jessica A. Kahn is often cited by papers focused on Cervical Cancer and HPV Research (116 papers), Vaccine Coverage and Hesitancy (48 papers) and Hepatitis B Virus Studies (47 papers). Jessica A. Kahn collaborates with scholars based in United States, Canada and Australia. Jessica A. Kahn's co-authors include Susan L. Rosenthal, Gregory D. Zimet, David I. Bernstein, Bin Huang, Dongmei Lan, Lili Ding, A. Lindsay Frazier, S. Bryn Austin, Graham A. Colditz and Marcia L. Shew and has published in prestigious journals such as New England Journal of Medicine, JAMA and PEDIATRICS.

In The Last Decade

Jessica A. Kahn

174 papers receiving 5.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jessica A. Kahn United States 43 4.0k 1.8k 1.4k 1.0k 664 180 5.9k
Laurie D. Elam–Evans United States 38 4.0k 1.0× 2.8k 1.5× 825 0.6× 1.0k 1.0× 398 0.6× 82 7.1k
Susan L. Rosenthal United States 49 4.5k 1.1× 3.6k 2.0× 1.3k 0.9× 2.1k 2.0× 757 1.1× 292 9.1k
Elissa Meites United States 26 2.7k 0.7× 1.0k 0.6× 1.0k 0.7× 732 0.7× 728 1.1× 70 4.0k
Harrell W. Chesson United States 41 6.0k 1.5× 1.8k 1.0× 1.8k 1.2× 1.8k 1.7× 1.8k 2.7× 178 9.4k
Gina Ogilvie Canada 44 5.3k 1.3× 986 0.5× 1.5k 1.0× 1.1k 1.0× 1.0k 1.5× 292 7.7k
Nicole Liddon United States 26 2.3k 0.6× 1.6k 0.9× 686 0.5× 930 0.9× 217 0.3× 63 3.6k
Heidi M. Bauer United States 29 2.2k 0.5× 994 0.5× 941 0.7× 875 0.8× 1.1k 1.6× 77 4.4k
Linda M. Niccolai United States 37 2.3k 0.6× 729 0.4× 537 0.4× 1.4k 1.3× 384 0.6× 181 4.3k
Annie‐Laurie McRee United States 36 2.5k 0.6× 2.3k 1.2× 690 0.5× 874 0.8× 122 0.2× 119 4.5k
Maya Sternberg United States 42 4.3k 1.1× 466 0.3× 1.6k 1.1× 1.8k 1.7× 2.2k 3.2× 114 8.3k

Countries citing papers authored by Jessica A. Kahn

Since Specialization
Citations

This map shows the geographic impact of Jessica A. Kahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jessica A. Kahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jessica A. Kahn more than expected).

Fields of papers citing papers by Jessica A. Kahn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jessica A. Kahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jessica A. Kahn. The network helps show where Jessica A. Kahn may publish in the future.

Co-authorship network of co-authors of Jessica A. Kahn

This figure shows the co-authorship network connecting the top 25 collaborators of Jessica A. Kahn. A scholar is included among the top collaborators of Jessica A. Kahn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jessica A. Kahn. Jessica A. Kahn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ding, Lili, Aaron Ermel, Eduardo L. Franco, et al.. (2025). Population-Level Effectiveness and Herd Protection 17 Years After HPV Vaccine Introduction. JAMA Pediatrics. 179(12). 1326–1326. 1 indexed citations
2.
3.
4.
Real, Francis J., Melissa Klein, Dominick DeBlasio, et al.. (2021). Evaluation of HPV Vaccine: Same Way, Same DayTM: A Pilot Study. Journal of Health Communication. 26(12). 839–845. 6 indexed citations
5.
6.
Tatar, Ovidiu, Erika L. Thompson, Anila Naz, et al.. (2018). Factors associated with human papillomavirus (HPV) test acceptability in primary screening for cervical cancer: A mixed methods research synthesis. Preventive Medicine. 116. 40–50. 26 indexed citations
7.
Rosen, Brittany L., et al.. (2018). Quality of Web-Based Educational Interventions for Clinicians on Human Papillomavirus Vaccine: Content and Usability Assessment. JMIR Cancer. 4(1). e3–e3. 12 indexed citations
8.
Widdice, Lea E., Rebecca Hoagland, S. Todd Callahan, et al.. (2018). Caregiver and adolescent factors associated with delayed completion of the three-dose human papillomavirus vaccination series. Vaccine. 36(11). 1491–1499. 8 indexed citations
9.
Mullins, Tanya L. Kowalczyk, et al.. (2018). Primary Care Physician Attitudes and Intentions Toward the Use of HIV Pre-exposure Prophylaxis in Adolescents in One Metropolitan Region. Journal of Adolescent Health. 64(5). 581–588. 27 indexed citations
10.
Kasting, Monica L., Shannon M. Christy, Steven K. Sutton, et al.. (2018). Florida physicians' reported use of AFIX-based strategies for human papillomavirus vaccination. Preventive Medicine. 116. 143–149. 9 indexed citations
11.
Franco, Eduardo L., et al.. (2017). Non–Vaccine-Type Human Papillomavirus Prevalence After Vaccine Introduction: No Evidence for Type Replacement but Evidence for Cross-Protection. Sexually Transmitted Diseases. 45(4). 260–265. 28 indexed citations
12.
Mullins, Tanya L. Kowalczyk, Gregory D. Zimet, Michelle Lally, et al.. (2017). HIV Care Providers' Intentions to Prescribe and Actual Prescription of Pre-Exposure Prophylaxis to At-Risk Adolescents and Adults. AIDS Patient Care and STDs. 31(12). 504–516. 56 indexed citations
13.
Mullins, Tanya L. Kowalczyk, et al.. (2016). Adolescent Human Immunodeficiency Virus Care Providers’ Attitudes Toward the Use of Oral Pre-Exposure Prophylaxis in Youth. AIDS Patient Care and STDs. 30(7). 339–348. 42 indexed citations
14.
Vadaparampil, Susan T., Teri L. Malo, Steven K. Sutton, et al.. (2016). Missing the Target for Routine Human Papillomavirus Vaccination: Consistent and Strong Physician Recommendations Are Lacking for 11- to 12-Year-Old Males. Carolina Digital Repository (University of North Carolina at Chapel Hill). 1 indexed citations
15.
Kasting, Monica L., Gilla K. Shapiro, Zeev Rosberger, Jessica A. Kahn, & Gregory D. Zimet. (2016). Tempest in a teapot: A systematic review of HPV vaccination and risk compensation research. PMC. 1 indexed citations
16.
Mullins, Tanya L. Kowalczyk, et al.. (2015). Clinician Attitudes Toward CDC Interim Pre-Exposure Prophylaxis (PrEP) Guidance and Operationalizing PrEP for Adolescents. AIDS Patient Care and STDs. 29(4). 193–203. 47 indexed citations
17.
Giguere, Rebecca, Alex Carballo‐Diéguez, Ana Ventuneac, et al.. (2011). Variations in microbicide gel acceptability among young women in the USA and Puerto Rico. Culture Health & Sexuality. 14(2). 151–166. 29 indexed citations
18.
Conroy, Kathleen, Susan L. Rosenthal, Gregory D. Zimet, et al.. (2009). Human Papillomavirus Vaccine Uptake, Predictors of Vaccination, and Self-Reported Barriers to Vaccination. Journal of Women s Health. 18(10). 1679–1686. 179 indexed citations
19.
Kahn, Jessica A., Gail B. Slap, David I. Bernstein, et al.. (2007). Personal meaning of human papillomavirus and pap test results in adolescent and young adult women.. Health Psychology. 26(2). 192–200. 79 indexed citations
20.
Kahn, Jessica A., Susan L. Rosenthal, Paul Succop, Gloria Ho, & Robert D. Burk. (2002). The interval between menarche and age of first sexual intercourse as a risk factor for subsequent HPV infection in adolescent and young adult women. The Journal of Pediatrics. 141(5). 718–723. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laurie D. Elam–Evans Breakdown of academic impact, for papers by Susan L. Rosenthal Breakdown of academic impact, for papers by Elissa Meites Breakdown of academic impact, for papers by Harrell W. Chesson Breakdown of academic impact, for papers by Gina Ogilvie Breakdown of academic impact, for papers by Nicole Liddon Breakdown of academic impact, for papers by Heidi M. Bauer Breakdown of academic impact, for papers by Linda M. Niccolai Breakdown of academic impact, for papers by Annie‐Laurie McRee Breakdown of academic impact, for papers by Maya Sternberg
Rankless by CCL
2026